Montefarmaco

What Montefarmaco does

Montefarmaco OTC S.p.A. is an Italian consumer health company founded in 1947 in Milan by pharmacist Dr. Giovanni Colombo and headquartered in Bollate (Milan), operating as a Società con Socio Unico under the Montefarmaco Holding umbrella with family (Colombo) governance. The company develops, manufactures, and distributes over-the-counter pharmaceuticals, medical devices, dietary supplements, and home care products organized across 18+ sub-brands spanning probiotics (Lactoflorene), ophthalmic care (Iridina, Afomill), oral health (Dentinale, Dr. Brux, Dottor K), throat and respiratory wellness (Pumilene, Propoli Mix Defend), energy and multivitamins (Briovitase, Vitalmix, Multivitamix, Orsovit), digestive health (Normalene, DREN), pain relief (Calmadol), dermocosmetics and skin wellness (MyCollagenLab, Ontherapy, Light and Silk Oil), and home care hardware (Pumilene Vapo diffusers and humidifiers, disinfectants). Its principal proprietary technology is the M-Cap System, a 100% Italian-patented packaging design for the Lactoflorene probiotic line that uses a press-shake-drink mechanism with a separator cap to preserve live lactic acid bacteria stability; the system won the Quality Design award at the 2020 Oscars of Packaging and is also licensed to third parties. Products are sold exclusively through the Italian pharmacy and parapharmacy channel, with the company explicitly positioning itself as pharmacy-born and pharmacy-oriented, supported by a dedicated diffuser/humidifier service center (toll-free 800.444.808) and an international trading subsidiary (Montefarmaco Trading (Shanghai) Co. Ltd) for the Chinese market. The company holds CE medical device certifications on relevant product lines, maintains AIFA-compliant pharmacovigilance processes, and earned a two-star Legality Rating from the Italian Antitrust Authority in 2024.

Name

Montefarmaco

Legal name

MONTEFARMACO OTC SPA SOCIETA' CON SOCIO UNICO

Website

https://montefarmaco.com

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

51–100 employees

Short description

Italian OTC pharmaceutical and dietary supplement company founded in 1947, serving Italian consumers through pharmacy and parapharmacy channels with a diversified portfolio of probiotics, ophthalmic, pain relief, dermocosmetic, and wellness products across 18+ sub-brands.

Ownership category

akta.pro rank

Product category

OTC Pharmaceuticals and Consumer Health

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

akta.pro secondary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• OTC pharmaceuticals
• Dietary supplements
• Probiotic formulations
• Medical devices
• Consumer health products

Headquarters

HQ city

Bollate

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. OTC Pharmaceuticals and Medical Devices: Montefarmaco generates revenue from the sale of over-the-counter pharmaceuticals (e.g., Normalene® with Bisacodyl, Dentinale®, Calmadol®), medical devices (e.g., Afomill® eye drops, Normalene® Macrogol 4000, Normalene® Stop Gas®), and dietary supplements (e.g., probiotics under the Lactoflorene® brand, vitamin supplements under Orsovit®, Vitalmix®, Briovitase®, Multivitamix®). Products are sold across multiple therapeutic and wellness categories including probiotics, ophthalmic, energy, laxatives, oral health, throat/breath, home care, dermocosmetics, pain, and feet care.
2. Home Care Products: Revenue from home care products including Pumilene® Vapo essential oil diffusers, humidifiers (cold and hot), disinfectants, and environmental essences. These products are sold through the pharmacy and parapharmacy channel.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Montefarmaco develops, manufactures and sells a broad portfolio of over-the-counter (OTC) pharmaceuticals, dietary supplements, medical devices and home care wellness products in Italy. Its range covers probiotics, ophthalmic, energy, laxatives, oral health, throat and respiratory care, pain relief, dermocosmetics, skin wellness and home environment products, sold under proprietary sub-brands such as Lactoflorene®, Afomill®, Orsovit®, Normalene®, Calmadol®, Pumilene® and Dr. Brux® through pharmacy and parapharmacy retail channels.

Product overview

Montefarmaco OTC S.p.A. is an Italian pharmaceutical company founded by Dr. Giovanni Colombo, pharmacist, headquartered in Bollate (Milan). The company operates as a pharmacy-focused OTC (over-the-counter) pharmaceutical business offering a diversified portfolio of consumer health and wellness products organized into distinct sub-brands. The product portfolio includes probiotics and gut health (Lactoflorene® line with multiple variants for adults, children, and babies), ophthalmic products (Iridina®, Afomill®), oral health solutions (Dentinale®, Dr. Brux®, Dottor K), throat and respiratory care (Pumilene®, Propoli Mix Defend), energy and vitality supplements (Briovitase®, Vitalmix®, Multivitamix®), children's vitamins (Orsovit® gummy multivitamins), digestive health/laxatives (Normalene®), pain relief (Calmadol®), skin wellness/dermocosmetics (MyCollagenLab®, Ontherapy®, Light and Silk Oil), home care (Pumilene® Vapo fragrances, diffusers, humidifiers, disinfectants), foot care, and hearing amplifiers (Amplificatori Acustika). The company also has a subsidiary Montefarmaco Trading (Shanghai) Co. Ltd.

Differentiator

Problem solved

Functional benefit

Brands

• Lactoflorene: Complete line of lactic acid bacteria with probiotic action for gut microbiota balance
• Orsovit
• Normalene
• Pumilene
• Calmadol
• Dr. Brux
• Iridina
• Dentinale
• Afomill
• MyCollagenLab
• Ontherapy
• Briovitase
• Vitalmix
• Multivitamix
• Dottor K
• Iristyle
• Light and Silk Oil

Products and services

• Lactoflorene® Complete line of probiotic lactic acid bacteria supplements in vials with the proprietary M-Cap System® separator cap, including variants for gut microbiota balance, cholesterol control, urinary tract support (Cist), flat belly, child defense and babies; sold in Italian pharmacies and parapharmacies.
• Afomill®
• Iridina®
• Orsovit®
• Normalene®
• Pumilene®
• Vitalmix®
• Briovitase®
• Multivitamix®
• Dentinale®
• Dr. Brux®
• Calmadol®
• Iristyle® reading glasses
• Pumilene® Home (diffusers, humidifiers, disinfectants)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature1 record

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Menarini: Italy's largest privately-held pharmaceutical company with a substantial OTC and consumer-health division distributed across European pharmacies. A broad incumbent that overlaps with Montefarmaco's respiratory, pain, and digestive categories.
• Recordati: Publicly-listed Italian specialty pharmaceutical group with a self-medication/OTC business unit selling through European pharmacies. Comparable OTC distribution overlap with Montefarmaco but at materially larger scale and broader geographic reach.
• Angelini: Large privately-held Italian pharmaceutical and consumer-health group with a broad OTC, personal care, and pharma portfolio sold across European retail and pharmacy channels. A larger-scale incumbent that competes with Montefarmaco across multiple OTC categories in Italy.
• Perrigo: Global OTC consumer-health company and one of the largest manufacturers of store-brand and branded OTC products in Europe, with deep pharmacy and retail distribution. A broad incumbent that competes with Montefarmaco's OTC portfolio in European pharmacy channels.
• Chiesi: Major Italian privately-held pharmaceutical group with consumer-health/OTC presence alongside its core prescription business. A broad incumbent competing with Montefarmaco in Italian pharmacy channels across several overlapping therapeutic categories.

Direct peers

• Zambon: Italian privately-held pharmaceutical group with a consumer-health division selling OTC and self-medication products through European pharmacies. Comparable to Montefarmaco in Italian heritage, OTC focus, and pharmacy-channel distribution.
• Specchiasol: Italian natural supplements company specializing in phytotherapy, probiotics, and OTC-style remedies sold primarily through Italian pharmacies. Directly comparable in channel and category overlap with Montefarmaco's Lactoflorene, Briovitase, and Vitalmix lines.
• Esi S.p.A. Italian dietary supplements and OTC manufacturer selling a broad multi-category portfolio through Italian pharmacies and parapharmacies. Comparable to Montefarmaco in scale, channel exclusivity, and product breadth across vitamins, probiotics, and wellness lines.
• Named (Named Sport): Italian dietary supplements and sports nutrition brand distributed through Italian pharmacies and parapharmacies. Comparable to Montefarmaco in channel exclusivity and in the energy/vitamin/Sport sub-categories (e.g., Vitalmix Ready Energy, Briovitase Sport).
• Aboca: Italian natural-health company headquartered in Tuscany that develops and markets herbal dietary supplements and medical devices through the Italian pharmacy channel. Closely comparable to Montefarmaco in channel strategy (pharmacy-first), country footprint (Italy-led), and category mix (probiotics, respiratory, digestive, dermatological).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCyEE-zRdioqeMdhn7L37ADQ
• Facebookfacebook.com/montefarmaco.otc
• LinkedInlinkedin.com/company/montefarmaco-otc-spa

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Montefarmaco